This week the US Food and Drug Administration approved the release of fingolimod (trade name Gilenya®), the first oral medication for the treatment of remitting relapsing multiple sclerosis. Swedish Neuroscience Institute is proud to have participated in the pivotal clinical trial that led to the approval of Gilenya. Gilenya is a welcome addition to the set of medications available to patients living with MS. There are currently five injectable therapies and two intravenous therapies approved by the FDA for the treatment of MS. Although these treatments are very effective, many patients have been hoping for an oral alternative. Some patients are finding that they have “injection fatigue” or are running out of places to inject the medication. It is important to note, however, that not all patients should switch to Gilenya. Patients with stable disease should remain on their medications. Patients need to be informed of the risks associated with Gilenya, including slowed heart rate, increased blood pressure, difficulty breathing, abnormal liver function, and infection, and how these risks may apply to them. If you are wondering whether Gilenya is right for you, please ask your neurologist.
A brisk walk for as little as 30 minutes a day can improve your health in many ways and may reduce your r...
Recommended for you
Learn about how COVID-19 may be causing strokes in younger people, warning signs to watch for and why you shouldn’t wait to get care.
Dementia and Healthy Aging: A Conversation with Dr. Nancy Isenberg
Find out what you can do to minimize the risk of stroke for yourself and your loved ones.
Creating & listening to music playlists is fun, but did you know it can be therapeutic? Here are some tips from a Board-Certified music therapist, to help fight cancer by finding just the right mix.
World Heart Day and World Stroke Day help build awareness about the benefits of healthy lifestyle choices and how you can reduce your risk of disease.
Find out how to improve emotional well-being for children and prevent mental health disorders before they begin.
Get answers to your questions about vertigo and balance issues from a Swedish audiologist.
Guided focus ultrasound technology is a promising, non-invasive treatment to mitigate essential tremor
New medication and therapies are being developed to mitigate tremors and permanent immobility caused by Parkinson’s disease.
The use of machine learning applications in diagnosing Alzheimer's is an exciting new development in medical research that promises to help overcome the difficulties of early diagnosis.
Aphasia treatment is spearheaded by a speech and language pathologist but draws on the professionalism and skill of numerous other specialties.
According to the World Health Organization, up to 75% of adults between 18 to 65 years old have had a headache in the last year. Of those, at least 30% have reported a migraine. Despite how...
Nirav H. Shah, MD, Medical Director of Stroke at the Swedish Neuroscience Institute, explains how strokes are caused, how they are treated and how to prevent them from happening.
Medical science has invested heavily in researching the brain, and one promising area that has garnered well-deserved attention is the increasing success of a medical procedure known as deep...
The Multiple Sclerosis Center at the Swedish Neuroscience Institute receives patients from all over the world wanting to confirm their MS diagnosis or seeking ways to manage their symptoms and...
A closer look at an all-too-familiar sensation of your hands and feet falling asleep.
When you think about epilepsy, you may think of seizures. But Lisa Caylor, MD, epileptologist at Swedish, associates epilepsy with a stigma she knows all too well.
Educate yourself on brain aneurysm for Brain Aneurysm Awareness Month.
Football season begins in a few short weeks; not only for the NFL but schools, as well. In September, kids across America will eagerly sign up for football and other contact sports. As a parent...
When brain cancer claimed Dennis Lisk’s life, his daughter Megan channeled her love for art into fundraising for the disease.